2012
DOI: 10.3892/or.2012.1714
|View full text |Cite
|
Sign up to set email alerts
|

A new bioinformatics insight into human cancer-associated proteins

Abstract: Abstract. Cancer is a complex disease caused by multiple factors including genetic mutations, and environmental factors. Cancer-associated proteins are potential biomarkers or targets for diagnostic and therapeutic interventions in cancer. The Universal Protein Resourse (UniPort) is a well-annotated comprehensive resourse for protein sequence records. In the present study, we performed data mining of UniProt proteins as a proteomic resource. We generated a catalog of 1653 cancer-associated proteins including 3… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2013
2013
2015
2015

Publication Types

Select...
5

Relationship

3
2

Authors

Journals

citations
Cited by 5 publications
(4 citation statements)
references
References 30 publications
0
4
0
Order By: Relevance
“…Certain genes that are highly-expressed in the testes or epididymis are promising markers for cancer (15,16). Of the 1,904 selectively-expressed genes, 52 were highly-expressed in the human testes and 30 in the epididymis.…”
Section: Resultsmentioning
confidence: 99%
“…Certain genes that are highly-expressed in the testes or epididymis are promising markers for cancer (15,16). Of the 1,904 selectively-expressed genes, 52 were highly-expressed in the human testes and 30 in the epididymis.…”
Section: Resultsmentioning
confidence: 99%
“…In this research, no teratoma were detected. However, the following are reasons that argue against this possibility: 1) The number of ES-implanted mice was limited; 2) Implantation time was short.We have completed bioinformatic studies of cancer-associated proteins [19] and have started studies to determine the associations of ESCs and tumors.…”
Section: Discussionmentioning
confidence: 99%
“…With the development and improvement of high-throughput biotechnologies, cancer biomarkers can be identified by comparing normal cells with cancer cells through genomic, transcriptomic and proteomic analyses. At present, the most promising biomarkers are proteins (2,3) and proteomic analysis provides an opportunity to identify altered protein groups and the complex pathways in breast cancer. The mapping of proteomic profiles and differential proteomics has been widely performed in breast cancer to identify potential biomarkers (4).…”
Section: Introductionmentioning
confidence: 99%